Loading clinical trials...
Loading clinical trials...
This is an open-label, 2-cohort study to evaluate the absolute bioavailability, absorption, distribution, metabolism and excretion of TD-1473 in healthy male subjects. Subjects in cohort 1 will receiv...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Theravance Biopharma
NCT05212129 · Functional Gastrointestinal Disorders, Hypermobile Ehlers-Danlos Syndrome, and more
NCT05880199 · Gastrointestinal Motility Disorders in Children, Functional Gastrointestinal Disorders, and more
NCT06573723 · Rare Diseases, Amyloidosis, and more
NCT07257835 · Eosinophilic Gastrointestinal Disorders (EGIDs)
NCT03823742 · Irritable Bowel Syndrome, Functional Abdominal Pain Syndrome, and more
Celerion
Lincoln, Nebraska
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions